Asthma and allergic diseases are a major public health problem, and their prevalence has been increasing in Finland and other developed countries since the 1960s [1,2]. Even though understanding of the origin of these conditions has improved in the last decades, tools for prevention are limited. The main aetiological hypotheses have varied over time. In the 1970-1980s, the main focus was on tobacco smoking and environmental pollution. In the 1990s, the "allergy epidemic" was linked with vaccinations, improved hygiene and reduced burden of infectious disease. During the last 10 years, reduced contact with environmental microbiota has been highlighted [3,4]. We report here the self-reported prevalence of asthma, hay fever or other allergic rhinitis and allergic eye symptom over a 15-year period among the Finnish adult population.The National FINRISK Study has been carried out at 5-year intervals since 1972 to monitor the levels of noncommunicable disease risk factors in Finland [5]. Questions related to asthma and allergic symptoms were included in the study protocol first time in 1997. The present study population consisted of participants of the four last rounds of the study conducted in 1997, 2002, 2007 and 2012. In each survey year, a random sample of 10 000 (8000 in 2012) 25-64-year-old men and women was taken. The participation rate varied from 65% to 72% and the total number of participants was 26 939. Data were collected using standardised self-administered questionnaires based on the European Community Respiratory Health Survey [6]. The study protocol was approved by the ethical committee and all participants gave informed consent.Prevalence of asthma was assessed based on responses to the question of whether the respondent has asthma diagnosed by a physician. Hay fever or other allergic rhinitis and allergic eye symptoms were assessed by asking whether the respondent: 1) had never had the symptoms, 2) had had the symptoms during the past 12 months prior the survey, or 3) had had the symptoms but not during the past 12 months. In each study year, the data collection was performed between January and March, before the main pollen season. Data were analysed adjusting for age and stratified by age groups. Statistical analyses were performed by the SAS 9.3 for Windows statistical package (SAS Institute, Cary, NC, USA). The significance of age-adjusted prevalence change over time was tested by the Chi-squared test and Wald confidence limits were used to calculate 95% confidence intervals. All analyses were done separately for men and women.